Financial Statements — APAD
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 0.43 | 1.45 | -- |
| Total Current Assets | 0.60 | 1.63 | 0.00 |
| Total Non-current Assets* | 205.11 | 201.38 | 0.10 |
| Total Assets | 205.71 | 203.01 | 0.10 |
| Total Current Liabilities | 0.61 | 0.47 | 0.39 |
| Total Non-current Liabilities* | 8.00 | 8.00 | 0.00 |
| Total Liabilities | 8.61 | 8.47 | 0.39 |
| Retained Earnings | (8.00) | (6.83) | (0.32) |
| Total Stockholder Equity | (8.00) | (6.83) | (0.29) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Selling, General & Admin | 0.01 | (0.11) | 0.17 | 0.02 |
| Operating Income | (0.37) | (0.81) | (0.17) | -- |
| Pretax Income | 1.42 | 1.14 | 1.48 | (0.02) |
| Net Income | 1.42 | 1.14 | 1.48 | (0.05) |
| Basic EPS | -- | -- | -- | 0.00 |
| Diluted EPS | -- | -- | -- | 0.00 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Operating Cash Flow | (0.21) | (0.46) | (0.27) | (0.05) |
| Investing Cash Flow | -- | -- | (200.00) | -- |
| Financing Cash Flow | (0.06) | (0.30) | 201.72 | 0.05 |
